Ys Biopharma Co. Ltd (YS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | YS | AMGN | VRTX | REGN | BMY |
| Company | Ys Biopharma Co. Ltd | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 0.7500 | 276.11 | 396.20 | 892.11 | 44.40 |
| High | 0.7800 | 276.12 | 396.69 | 896.85 | 44.76 |
| Low | 0.7040 | 272.35 | 391.70 | 885.01 | 43.93 |
| Last | 0.7040 | 273.94 | 392.81 | 890.66 | 43.94 |
| Change | -0.0660 | -2.44 | -3.39 | -1.82 | -0.70 |
| % Change | -8.57% | -0.88% | -0.86% | -0.20% | -1.57% |
| Volume | 54,200 | 2,477,300 | 1,727,900 | 636,600 | 17,715,900 |
| 20-Day Average Volume | 169,295 | 2,210,300 | 973,120 | 467,490 | 13,924,890 |
| Previous Close | 0.7700 | 276.38 | 396.20 | 892.48 | 44.64 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.8334 | 269.54 | 399.24 | 911.50 | 48.61 |
| 20-Day Raw Stochastic | 1.22% | 81.95% | 7.52% | 17.75% | 0.11% |
| 20-Day Relative Strength | 47.53% | 49.60% | 39.26% | 36.96% | 27.04% |
| Weighted Alpha | -53.00 | +12.61 | +11.10 | +14.87 | -36.77 |
| Today's Opinion | 24% Buy | 40% Sell | 24% Sell | 8% Buy | 88% Sell |
| Previous Opinion | 48% Buy | 24% Sell | 8% Sell | 8% Buy | 88% Sell |
| Last Month's Opinion | 8% Buy | 24% Buy | 56% Buy | 96% Buy | 8% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -13.18% since 04/23/24 | +0.15% since 04/23/24 | -2.99% since 04/23/24 | -1.84% since 04/23/24 | -10.31% since 04/23/24 |
| Low | 0.7040 on 04/30/24 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 43.93 on 04/30/24 |
| High | 0.8500 on 04/26/24 | 276.86 on 04/29/24 | 406.83 on 04/24/24 | 915.70 on 04/24/24 | 49.04 on 04/24/24 |
| 1-Month | |||||
| %Chg | -2.21% since 03/28/24 | -3.65% since 03/28/24 | -6.03% since 03/28/24 | -7.46% since 03/28/24 | -18.97% since 03/28/24 |
| Low | 0.7000 on 04/19/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.93 on 04/30/24 |
| High | 1.0285 on 04/04/24 | 283.91 on 04/02/24 | 421.45 on 04/01/24 | 970.20 on 04/01/24 | 54.23 on 04/01/24 |
| 3-Month | |||||
| %Chg | +57.92% since 01/30/24 | -12.93% since 01/30/24 | -11.94% since 01/30/24 | -7.20% since 01/30/24 | -11.03% since 01/30/24 |
| Low | 0.3503 on 02/02/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.93 on 04/30/24 |
| High | 1.0285 on 04/04/24 | 329.72 on 02/05/24 | 444.07 on 01/31/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | +57.74% since 10/30/23 | +4.08% since 10/30/23 | +9.89% since 10/30/23 | +14.53% since 10/30/23 | -14.26% since 10/30/23 |
| Low | 0.3503 on 02/02/24 | 249.70 on 10/31/23 | 341.90 on 11/16/23 | 772.84 on 10/31/23 | 43.93 on 04/30/24 |
| High | 1.0285 on 04/04/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 71,655 | 148,243,600 | 102,401,456 | 97,960,392 | 90,489,744 |
| Shares Outstanding, K | 93,058 | 536,376 | 258,459 | 109,762 | 2,027,100 |
| Annual Sales | 100,000,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -21,170,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 13,640,000 | 8,196,000,000 | 2,517,700,000 | 3,434,300,000 | 11,865,000,000 |
| Last Quarter Net Income | -14,680,000 | 767,000,000 | 968,800,000 | 1,159,600,000 | -11,911,000,000 |
| 60-Month Beta | 0.52 | 0.58 | 0.35 | 0.11 | 0.39 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.16 on 01/22/24 | 4.71 on 02/06/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 04/19/24 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.48 | 29.57 | 23.50 | 42.71 |